ABSTRACT
The aim of this study was to assess the toxicological responses of a resin composite containing TiK2F6 and NaF in rat dental pulp cells. Trial resin composite liners were made, containing 3 wt% fluorides (TiK2F6 or NaF). These specimens were immersed in 5 ml of cell culture medium supplemented at 37 degrees C for 24 hours. The eluates were used for the experiments. We judged the cytotoxicity of the samples by the cell viability. The original elute solution was serially diluted and then the medium was exchanged for the dilute medium. The cell viability at 1, 2 or 5 days after commencement of re-culturing was calculated. The viability of cells in the eluate from the resin composite liners containing TiK2F6 and NaF decreased with time. The cytotoxicity of TiK2F6 was weaker than that of NaF at all times.
Subject(s)
Cariostatic Agents/toxicity , Composite Resins/toxicity , Dental Pulp/drug effects , Fluorides/toxicity , Potassium Compounds/toxicity , Sodium Fluoride/toxicity , Titanium/toxicity , Animals , Cell Survival/drug effects , Clone Cells , Dental Cavity Lining/adverse effects , Dental Pulp/cytology , Materials Testing , RatsABSTRACT
PURPOSE: To evaluate the in vitro secondary caries inhibitory effect of two resin-modified glass ionomer cements (R-GICs). MATERIALS AND METHODS: Class V cavities were prepared at the cementoenamel junction on facial and lingual surfaces of 32 extracted upper premolars. The facial cavities were restored with a conventional glass ionomer cement (GIC) (Fuji II), while the lingual cavities were restored with either one of the R-GICs (Fuji II LC, Photac Fil, Vitremer), or a resin composite (Z-100). The margins of the restorations were subjected to a 20-day in vitro cariogenic challenge and the degree of demineralization was analyzed by microradiography. The amounts of fluoride released into distilled water from disc specimens of the materials tested were also measured for immersion time up to 161 days. RESULTS: The R-GICs and GIC's released similar cumulative amounts of fluoride over 161 days. Photac-Fil showed significantly higher amounts of fluoride release over the same period. The depth of the outer lesion and the thickness of the acid-resistant layer showed no significant difference among the R-GICs and GIC's. Moreover, the residual fluoride and calcium in the dentin adjacent to the R-GICs and GIC's were correlated with the thickness of acid-resistant layers in the dentin adjacent to the R-GICs and GIC's by electron probe microanalysis. However, the inhibitory effect of the R-GICs was not directly related to the fluoride concentrations eluted from them.
Subject(s)
Composite Resins/therapeutic use , Dental Caries/therapy , Glass Ionomer Cements/therapeutic use , Resins, Synthetic/therapeutic use , Bicuspid , Composite Resins/chemistry , Dental Caries/diagnosis , Dentin/chemistry , Drug Evaluation, Preclinical , Electron Probe Microanalysis , Fluorides/analysis , Glass Ionomer Cements/chemistry , Humans , In Vitro Techniques , Materials Testing , Maxilla , Recurrence , Resins, Synthetic/chemistryABSTRACT
We examined whether pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) is capable of improving thrombocytopenia and promoting thrombopoietic reconstitution following lethal irradiation and bone marrow transplantation (BMT) in mice. Immediately after receiving 10 Gy whole body irradiation (day 0), male C3H/HeN mice were inoculated with 10(6) bone marrow cells obtained from syngeneic mice. Circulating platelet counts decreased to below 4% of the normal counts with a nadir on day 10, and then returned to the normal level on day 28 in the control mice undergoing BMT. Subcutaneous consecutive treatment with PEG-rHuMGDF at doses from 10 to 300 micrograms/kg/day from day 1 for 13 days significantly improved the platelet nadir and promoted platelet recovery. The white blood cell counts and hemoglobin concentration following BMT were not influenced by the PEG-rHuMGDF. PEG-rHuMGDF-injection starting from day 5 did not improve the platelet nadir following BMT. Furthermore, administration with PEG-rHuMGDF on alternate days at 55.7 micrograms/kg/day for 7 days or at an interval of 3 days at 78 micrograms/kg/day for 4 days (twice a week for 2 weeks) had a significant efficacy, but these administration regimens had less efficacy than consecutive administration at 30 micrograms/kg/day for 13 days. The numbers of megakaryocytes and megakaryocyte progenitor cells decreased to 5 and 0.2% of normal level, respectively, in the control mice. Consecutive administration of PEG-rHuMGDF enhanced the recovery of the mean number of these cells compared to those in vehicle-treated mice, although such effects were not statistically significant except for the number of megakaryocyte progenitors on day 12. These results suggest that consecutive treatment with PEG-rHuMGDF beginning from the day after BMT may be effective in improving thrombocytopenia following BMT.
Subject(s)
Bone Marrow Transplantation , Polyethylene Glycols/therapeutic use , Thrombocytopenia/drug therapy , Thrombopoietin/therapeutic use , Animals , Drug Administration Schedule , Drug Evaluation, Preclinical , Male , Mice , Mice, Inbred C3H , Platelet Count/drug effects , Polyethylene Glycols/administration & dosage , Radiation Chimera , Recombinant Proteins/administration & dosage , Recombinant Proteins/therapeutic use , Thrombocytopenia/etiology , Thrombopoietin/administration & dosage , Transplantation Conditioning/adverse effects , Whole-Body Irradiation/adverse effectsABSTRACT
We present a case of fat embolism syndrome following vegetable oil injection for augmentation mammaplasty. Although vegetable oil is a stable neutral fat under usual storage conditions, it caused fat embolism and pulmonary injury in this patient. We investigated this mechanism by compound analysis of the injected oil, transbronchial lung biopsy and special staining of alveolar macrophages. This is the first description of the human response to vegetable oil injection. These data should aid in the investigation of the side effects of many types of lipids which may be applied to humans for various purposes in the future.
Subject(s)
Embolism, Fat/etiology , Mammaplasty/adverse effects , Plant Oils/adverse effects , Respiratory Distress Syndrome/etiology , Adult , Biopsy , Female , Humans , Infusions, Intravenous , Mammaplasty/methods , Respiratory Distress Syndrome/pathologyABSTRACT
Trichlorobiphenyl induced only CYP1A2 mRNA, while pentachlorobiphenyl induced both CYP1A2 and CYP2B1 mRNAs in rat liver. The mRNA levels for these P450s were elevated when ascorbic acid-deficient ODS rats (mutant rats with a hereditary osteogenic disorder) were fed a diet supplemented with ascorbic acid. The amount of CYP2B1 mRNA increased rapidly and reached a maximum level of approximately double within 24 hr of injection of pentachlorobiphenyl. Thereafter, the amount of its mRNA decreased to a steady level. This pattern was roughly paralleled by changes in the amount of CYP1A2 mRNA.